Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
AstraZeneca
Chinese Patent Office
Mallinckrodt
Deloitte
Farmers Insurance
QuintilesIMS
Merck

Generated: February 23, 2019

DrugPatentWatch Database Preview

Drug Price Trends for BANOPHEN

« Back to Dashboard

Drug Price Trends for BANOPHEN

Average Pharmacy Cost for BANOPHEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BANOPHEN ANTI-ITCH 2% CREAM 00904-5354-31 0.07153 GM 2019-02-20
BANOPHEN 25 MG CAPSULE 00904-2035-24 0.02999 EACH 2019-02-20
BANOPHEN 25 MG CAPSULE 00904-5306-60 0.02999 EACH 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for BANOPHEN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
BANOPHEN 25MG MINITAB BOXED Major Pharmaceuticals 00904-5551-24 24 0.68 0.02833 EACH 2018-12-01 - 2023-11-30 FSS
BANOPHEN 25MG MINITAB BOXED Major Pharmaceuticals 00904-5551-59 100 1.03 0.01030 EACH 2018-12-01 - 2023-11-30 FSS
BANOPHEN OTC CAP Major Pharmaceuticals 00904-2035-24 24 0.66 0.02750 EACH 2018-12-01 - 2023-11-30 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Merck
Fuji
Harvard Business School
Express Scripts
Moodys
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.